Sampling a GDB-20 Database of 32 Trillion Drug-Like Molecules by Generative Artificial Intelligence
Abstract
Identifying new chemical entities for small molecule drug discovery requires the continued exploration of its vast chemical space, which has been speculated to contain 10 60 or more molecules. Here we used generative artificial intelligence to sample a GDB-20 database estimated to contain 32 trillion organic molecules corresponding to 26.9 million molecular graphs up to 20 nodes selected for their limited topological complexity. We show that GDB-20 populates a distinct chemical space of sp 3-rich, 3D-shaped and natural product-like molecules with favorable synthetic accessibility score. The relevance for drug discovery of our 12 billion sample, named GDB-20s and representing 0.04% of the full database, is evidenced by high compliance with drug-likeness and toxicity filters, and the coverage of thousands of scaffolds occurring in bioactive molecules recorded in the ChEMBL database. The generative models for GDB-20 and the 12 billion sample are available for download at https://gdb.unibe.ch.
Fields of Study & Subjects
Computational Drug Discovery Methods
Machine Learning in Materials Science
Topological and Geometric Data Analysis
Publication details
- Journal / source
- ChemRxiv
- Publisher
- American Chemical Society (ACS)
- Publication date
- 22 February 2026
- Document type
- Preprint